APA

Sneller M. C., Clarridge K. E., Seamon C., Shi V., Zorawski M. D., Justement J. S., Blazkova J., Huiting E. D., Proschan M. A., Mora J. R., Shetzline M., Moir S., Lane H. C., Chun T. & Fauci A. S. (20200820). An open-label phase 1 clinical trial of the anti-α. : Science translational medicine.

Chicago

Sneller Michael C, Clarridge Katherine E, Seamon Catherine, Shi Victoria, Zorawski Marek D, Justement Jesse Shawn, Blazkova Jana, Huiting Erin D, Proschan Michael A, Mora Jorge Rodrigo, Shetzline Michael, Moir Susan, Lane Henry Clifford, Chun Tae-Wook and Fauci Anthony S. 20200820. An open-label phase 1 clinical trial of the anti-α. : Science translational medicine.

Harvard

Sneller M. C., Clarridge K. E., Seamon C., Shi V., Zorawski M. D., Justement J. S., Blazkova J., Huiting E. D., Proschan M. A., Mora J. R., Shetzline M., Moir S., Lane H. C., Chun T. and Fauci A. S. (20200820). An open-label phase 1 clinical trial of the anti-α. : Science translational medicine.

MLA

Sneller Michael C, Clarridge Katherine E, Seamon Catherine, Shi Victoria, Zorawski Marek D, Justement Jesse Shawn, Blazkova Jana, Huiting Erin D, Proschan Michael A, Mora Jorge Rodrigo, Shetzline Michael, Moir Susan, Lane Henry Clifford, Chun Tae-Wook and Fauci Anthony S. An open-label phase 1 clinical trial of the anti-α. : Science translational medicine. 20200820.